SYNTA PHARMACEUTICALS

synta-pharmaceuticals-logo

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. It has a global partnership with Roche for developing novel CRACM inhibitors, an oral calcium released activated calcium modulator ion channel inhibitor program that is in the lead optimization stage for the treatment of autoimmune disea... ses. The company also retains rights in various indications and markets to its other drug candidates and programs, which include STA-9090, an Hsp90 inhibitor that is in Phase 1 development; elesclomol, an oxidative stress inducer for the treatment of cancer; and apilimod, an oral IL-12/23 inhibitor, which is in Phase 2 for rheumatoid arthritis. In addition, Synta Pharmaceuticals Corp. is developing STA-9584, a vascular disrupting agent that is in preclinical development. The company was incorporated in 2000 and is based in Lexington, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

SYNTA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
2000-01-01

Address:
Lexington, Massachusetts, United States

Country:
United States

Website Url:
http://www.syntapharma.com

Total Employee:
51+

Status:
Active

Contact:
(781) 274-8200

Email Addresses:
[email protected]

Total Funding:
217.35 M USD

Technology used in webpage:
SPF Amazon Google Maps GoDaddy DNS Google Maps API AWS Global Accelerator AppRiver


Similar Organizations

3z-pharmaceuticals-logo

3Z Pharmaceuticals

3Z Pharmaceuticals focuses on developing drugs that would improve the central nervous system.

altrubio-logo

AltruBio

AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.

acadia-pharmaceuticals-inc-logo

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

adastra-pharmaceuticals-logo

Adastra Pharmaceuticals

Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.

aeovian-pharmaceuticals-logo

Aeovian Pharmaceuticals

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

alion-pharmaceuticals-logo

Alion Pharmaceuticals

Alion Pharmaceuticals is on developing a pipeline of small molecules with high potential

anthera-pharmaceuticals-logo

Anthera Pharmaceuticals

Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

arena-pharmaceuticals-logo

Arena Pharmaceuticals

Arena Pharmaceuticals is focused on delivering solutions for cardiovascular, central nervous system, inflammatory and metabolic diseases.

berry-genomics-logo

Berry Genomics

Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.

bionpharma-logo

BionPharma

BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.

boston-therapeutics-logo

Boston Therapeutics

Boston Therapeutics develops and commercializes novel compounds for unmet medical needs in the areas of diabetes and inflammatory diseases.

astria-therapeutics-logo

Astria Therapeutics

Astria Therapeutics discovers and develops innovative drugs for treating inflammatory conditions.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

concert-pharmaceuticals-logo

Concert Pharmaceuticals

Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates.

dynamis-pharmaceuticals-logo

Dynamis Pharmaceuticals

Dynamis Pharmaceuticals is a biopharma company that is developing proprietary small molecule drugs to treat chronic inflammatory diseases.

enanta-pharmaceuticals-logo

Enanta Pharmaceuticals

Enanta Pharmaceuticals is an R&D company discovers, develops and promotes of small molecule drugs in the areas of anti-infective.

eolo-pharma-logo

Eolo Pharma

Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases

kiora-pharmaceuticals-logo

Kiora Pharmaceuticals

Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.

glycovax-pharma-logo

Glycovax Pharma

Glycovax Pharma focuses on developing nano-medicines to treat cancers and other diseases.

haemalogix-logo

Haemalogix

Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.

hebecell-logo

HebeCell

HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.

icon-bioscience-logo

Icon Bioscience

Icon Bioscience develops and commercializes novel ophthalmic pharmaceuticals through a proprietary drug delivery platform.

kalgene-pharmaceuticals-logo

KalGene Pharmaceuticals

KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

nirogy-therapeutics-logo

Nirogy Therapeutics

Nirogy Therapeutics is focusing on small-molecule drugs that target the solute carrier family of transporter proteins (SLCTs).

oncoarendi-therapeutics-logo

OncoArendi Therapeutics

OncoArendi Therapeutics specialized in developing and commercializing of therapeutics for neoplastic and inflammatory diseases.

paxvax-logo

PaxVax

PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.

eyepoint-pharmaceuticals-logo

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.

renew-biopharma-inc-logo

Renew Biopharma Inc.

Pre-clinical stage syn-bio creating proprietary drug molecules to treat neuroinflammatory diseases .

ritter-pharmaceuticals-logo

Ritter Pharmaceuticals

Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

scilex-pharmaceuticals-logo

Scilex Pharmaceuticals

Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.

spring-bank-pharmaceuticals-logo

Spring Bank Pharmaceuticals

Spring Bank Pharmaceuticals is a discovery company developing a new class of pharmaceuticals called small molecule nucleic acid hybrids.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

venatorx-pharmaceuticals-logo

Venatorx Pharmaceuticals

Venatorx Pharmaceuticals develops a novel anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.

vertex-pharmaceuticals-logo

Vertex Pharmaceuticals

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.


Current Advisors List

robert-wilson_image

Robert Wilson Member of Board of Directors @ Synta Pharmaceuticals
Board_member

Current Employees Featured

chen-schor_image

Chen Schor
Chen Schor President and CEO @ Synta Pharmaceuticals
President and CEO

andrew-j-sonderfan_image

Andrew J. Sonderfan
Andrew J. Sonderfan Vice President, Drug Disposition and Preclinical Safety @ Synta Pharmaceuticals
Vice President, Drug Disposition and Preclinical Safety

lisa-bruneau_image

Lisa Bruneau
Lisa Bruneau Senior Director Finance @ Synta Pharmaceuticals
Senior Director Finance
2004-05-01

keith-ehrlich_image

Keith Ehrlich
Keith Ehrlich CFO @ Synta Pharmaceuticals
CFO

arthur-mcmahon_image

Arthur McMahon
Arthur McMahon Senior Vice President, Human Resources @ Synta Pharmaceuticals
Senior Vice President, Human Resources

suresh-babu_image

Suresh Babu
Suresh Babu Senior Vice President @ Synta Pharmaceuticals
Senior Vice President

Founder


safi-bahcall_image

Safi Bahcall

Stock Details


Company's stock symbol is NASDAQ:SNTA

Acquisitions List

Date Company Article Price
2016-04-14 Madrigal Pharmaceuticals Madrigal Pharmaceuticals acquired by Synta Pharmaceuticals 253.9 M USD

Investors List

galleon-group_image

Galleon Group

Galleon Group investment in Series C - Synta Pharmaceuticals

duquesne-capital-management_image

Duquesne Capital Management

Duquesne Capital Management investment in Series C - Synta Pharmaceuticals

mountain-trail-investments_image

Mountain Trail Investments

Mountain Trail Investments investment in Series C - Synta Pharmaceuticals

sunamerica_image

SunAmerica

SunAmerica investment in Series C - Synta Pharmaceuticals

caxton-associates_image

Caxton Associates

Caxton Associates investment in Series C - Synta Pharmaceuticals

gollust-management_image

Gollust Management

Gollust Management investment in Series C - Synta Pharmaceuticals

Official Site Inspections

http://www.syntapharma.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Synta Pharmaceuticals" on Search Engine